Dividends CalendarEarnings Calendar

EDIT | Editas

60.56 -4.81 (-7.36%) 

Company profile

  • Industry: Biotechnology
  • Sector: Healthcare
  • Headquarters:   Massachusetts, United States
  • Number of employees::   89

Company profile

Editas Medicine is building the leading genome editing company dedicated to treating patients with genetically defined diseases.

About the Company

Editas Medicine is a discovery-phase pharmaceutical company based in Cambridge, Massachusetts which aims to develop therapies based on CRISPR–Cas9 gene editing technology. The company went public on 2 Feb 2016.

  • Revenue: 6.05M


11 Hurley Street
Cambridge, MA 02141
United States

  • Total Assets:   508.9 million USD (2019)

Key Persons / Board of Directors

  • CEO :  Katrine S. Bosley

Jump to (Finance sites)


If you are looking for News & events, Press Release, they are available on their Investors Relationssite.

BUY 40

Their Official Profiles 


Peers / Similar stocks 


Other stocks 

pg orcl wfc hrl rost wmb sptn schw bkng ostk tal mrvl 

Support this project

If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
More features coming soon :)

Social Media 

Recommended Books

How to Day Trade for a Living
Buy on Amazon

Very few careers can offer you the freedom, flexibility, and income that day trading does. As a day trader, you can live and work anywhere in the world. You can decide when to work and when not to work. You only answer to yourself. That is the life of the successful day trader. Many people aspire to it, but very few succeed.

A Beginner's Guide to Trading Tools and Tactics, Money Management, Discipline and Trading Psychology